d-iva
d-iva: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Development Pipeline (1)
| Company | Phase |
|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Phase 3 |
Clinical Trials (1)
A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study Evaluating Safety and Pharmacokinetics of VX-581 in Healthy Subjects
Frequently asked questions
Who is developing d-iva?
d-iva is being developed by VERTEX PHARMACEUTICALS INC / MA.
How many clinical trials involve d-iva?
BioSniper tracks 1 clinical trial involving d-iva.
Analyze VERTEX PHARMACEUTICALS INC / MA & d-iva with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company